EUVIMEDEUVIMED entdecken
Crossref

DNAzyme‐Mediated Cascade Nanoreactor for Cuproptosis‐Promoted Pancreatic Cancer Synergistic Therapy

Qiao Yu, Jie Zhou, Yong Liu, Xiao Qiong Li, Shan Li, Hong Zhou, Bin Kang, Hong-Yuan Chen, Jing-Juan Xu iD

Advanced Healthcare Materials · 2023-11 · 12 (28)

DOI: 10.1002/adhm.202301429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 10.08.2023. Verfasst von Qiao Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering Nanjing University, Nanjing, 210023, P. R…. Hauptthemen laut MEDLINE: DNA, Catalytic, Nanoparticles, Neoplasms, Pancreatic Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: State Key Laboratory of Analytical Chemistry for Life Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, a kind of newly recognized cell death modality, shows enormous prospect in cancer treatment. The inducer of cuproptosis has more advantages in tumor therapy, especially that can trigger cuproptosis and chemodynamic therapy (CDT) simultaneously. However, cuproptosis is restricted to the deficiency of intracellular copper ions and the nonspecific delivery of copper‐based ionophores. Therefore, high level delivery, responsive release, and utilizing synergistic‐function of inducer become the key on cuproptosis‐based oncotherapy. In this work, a cascade nanosystem is constructed for enhanced cuproptosis and CDT. In the weak acidic environment of tumor cells, DNA, zinc ions, and Cu + can release from the nanosystem. Since Cu + having superior performance in mediating both Fenton‐like reaction and cuproptosis, the released Cu + induces cuproptosis and CDT efficiently, accompanied by Cu 2+ generation. Then Cu 2+ can be converted into Cu + partially by glutathione (GSH) to from a Cu + supply loop and ensure the synergistic action. Meanwhile, the consumption of GSH also contributes to cuproptosis and CDT in return. Finally, DNA and Zn 2+ form DNAzyme to shear catalase‐related RNA, resulting in the accumulation of hydrogen peroxide and further enhancing combination therapy. These results provide a promising nanotherapeutic platform and may inspire the design for potential cancer treatment based on cuproptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, CatalyticNanoparticlesNeoplasmsPancreatic NeoplasmsApoptosisHumansCell Line, TumorCopperGlutathioneHydrogen PeroxideNanotechnologyTumor Microenvironment

Stichwörter der Autor:innen

DNA enzymescascade nanoreactorschemodynamic therapycuproptosissynergistic therapy

Substanzen

CopperDNA, CatalyticGlutathioneHydrogen Peroxide

Autor:innen und Institutionen

  • State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering Nanjing University, Nanjing, 210023, P. R. China.
  • Key Laboratory of Optic-electric Sensing and Analytical Chemistry for Life Science, Ministry of Education, College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao, 266042, P…

ORCID-Profile: Jing-Juan Xu

Förderung

  • State Key Laboratory of Analytical Chemistry for Life Science

Zitieren

APA

Yu, Q., Zhou, J., Liu, Y., Li, X. Q., Li, S., Zhou, H., Kang, B., Chen, H. Y., & Xu, J. J. (2023). DNAzyme‐Mediated Cascade Nanoreactor for Cuproptosis‐Promoted Pancreatic Cancer Synergistic Therapy. Advanced Healthcare Materials, 12(28). https://doi.org/10.1002/adhm.202301429

Vancouver

Yu Q, Zhou J, Liu Y, Li XQ, Li S, Zhou H, et al. DNAzyme‐Mediated Cascade Nanoreactor for Cuproptosis‐Promoted Pancreatic Cancer Synergistic Therapy. Advanced Healthcare Materials. 2023;12(28). doi:10.1002/adhm.202301429

BibTeX
@article{Yu2023,
  author = {Yu, Qiao and Zhou, Jie and Liu, Yong and Li, Xiao Qiong and Li, Shan and Zhou, Hong and Kang, Bin and Chen, Hong-Yuan and Xu, Jing-Juan},
  title = {DNAzyme‐Mediated Cascade Nanoreactor for Cuproptosis‐Promoted Pancreatic Cancer Synergistic Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {28},
  doi = {10.1002/adhm.202301429}
}
Kostenlos starten →